CDSCO speeds up the process: automated certificates for medical devices

India has introduced a new step toward regulatory efficiency in the MedTech sector. Yet something has shifted for medical device manufacturers in India: the Central Drugs Standard Control Organization (CDSCO) has launched an automated certification process. There was no official statement or major digitalisation campaign, just a concrete step toward reduced delays and improved efficiency.

From now on, Market Standing Certificates (MSC) and Non-Conviction Certificates (NCC) for already authorized devices will be generated automatically. A seemingly small change, but with significant impact.

Why it matters

With regulatory work often slowed by administrative redundancies and procedural delays, the launch of CDSCO’s automated certification system represents a welcome shift. By automating key documents like the MSC and NCC, the Indian authority is enhancing procedural transparency and operational efficiency.

Rather than relying on traditional processes, this update reflects a broader move toward digital maturity in regulatory affairs—subtle, but with wide-reaching impact for both domestic and international stakeholders.

Looking at India from the outside

For international manufacturers, this development could unlock real opportunities. Easier access to regulatory documentation can accelerate registration processes, strengthen ties with local importers, and boost responsiveness during audits or official queries.

In a complex market like India, every operational advantage counts. That’s where strategy comes in: understanding the system, adapting to it, and staying ahead of the curve.

If you’re exploring medical device registration in India and want expert guidance tailored to your needs, we’re ready to support you.

Explore our India registration service and take the next step toward compliant market access in India.